Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global expression vectors market, 2015  2021 USD Million)

2.2. Global expression vectors market : Snapshot

Chapter 3. Expression Vectors  Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global expression vectors market drivers: Impact analysis

3.2.2. Strong demand of protein-based drugs

3.3. Market restraints


3.3.1. Global expression vectors market restraints: Impact analysis

3.3.2. High cost of protein therapy

3.4. Opportunities


3.4.1. Technology advancements

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by host segment

3.6.2. Market attractiveness analysis, by end-user segment

3.6.3. Market attractiveness analysis, by application segment

3.6.4. Market attractiveness analysis, by regional segment

Chapter 4. Global Expression Vectors Market  Competitive Landscape


4.1. Company market share, 2015 (Subject To Data Availability)


4.1.1. Global cellulose acetate market: company market share, 2015

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Host Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Host and Regional Expansion

4.3. Host Portfolio

4.4. Patent Analysis (2011-2016)


4.4.1. Patent Trend

4.4.2. Patent Share by company

4.4.3. By Region

Chapter 5. Global Expression Vectors Market  Host Analysis


5.1. Global expression vectors market: Host overview


5.1.1. Global expression vectors market revenue share, by host, 2015 - 2021

5.2. Bacteria


5.2.1. Global expression vectors market for bacteria, 2015 - 2021 (USD Million)

5.3. Yeast


5.3.1. Global expression vectors market for yeast, 2015 - 2021 (USD Million)

5.4. Insect


5.4.1. Global expression vectors market for insect, 2015 - 2021 (USD Million)

5.5. Others


5.5.1. Global expression vectors market for mammalian, 2015 - 2021 (USD Million)

Chapter 6. Global Expression Vectors Market  Application Analysis


6.1. Global expression vectors market: Application overview


6.1.1. Global expression vectors market revenue share, by application, 2015 - 2021

6.2. Therapeutic


6.2.1. Global expression vectors market for therapeutic, 2015 - 2021 (USD Million)

6.3. Industrial


6.3.1. Global expression vectors market for industrial, 2015 - 2021 (USD Million)

6.4. Research


6.4.1. Global expression vectors market for research, 2015 - 2021 (USD Million)

Chapter 7. Global Expression Vectors Market  End-users Analysis


7.1. Global expression vectors market: end-users overview


7.1.1. Global expression vectors market revenue share, by end-users, 2015 - 2021

7.2. Biotechnology  Pharmaceutical Companies


7.2.1. Global expression vectors market for biotechnology  Pharmaceutical Companies, 2015 - 2021 (USD Million)

7.3. CROs  CMOs


7.3.1. Global expression vectors market for (CROs)  (CMOs), 2015 - 2021 (USD Million)

7.4. Academic Research Institutes


7.4.1. Global expression vectors market for academic research Institutes, 2015 - 2021 (USD Million)

Chapter 8. Global Expression Vectors Market  Regional Segment Analysis


8.1. Global expression vectors market: Regional overview


8.1.1. Global expression vectors market revenue share, by region, 2015 - 2021

8.2. North America


8.2.1. North America expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.2.2. North America expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.2.3. North America expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.2.4. U.S.


8.2.4.1. U.S. expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.2.4.2. U.S. expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.2.4.3. U.S. expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.3. Europe


8.3.1. Europe expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.3.2. Europe expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.3.3. Europe expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.3.4. Germany


8.3.4.1. Germany expression vectors market revenue, by host, 2015 - 2021, (USD Million)

8.3.4.2. Germany expression vectors market revenue, by application, 2015 - 2021, (USD Million)

8.3.4.3. Germany expression vectors market revenue, by end-user, 2015 - 2021, (USD Million)

8.3.5. France


8.3.5.1. France expression vectors market revenue, by host, 2015 - 2021, (USD Million)

8.3.5.2. France expression vectors market revenue, by application, 2015 - 2021, (USD Million)

8.3.5.3. France expression vectors market revenue, by end-user, 2015 - 2021, (USD Million)

8.3.6. UK


8.3.6.1. UK expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.3.6.2. UK expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.3.6.3. UK expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.4. Asia Pacific


8.4.1. Asia Pacific expression vectors market revenue, by host, 2015 - 2021, (USD Million)

8.4.2. Asia Pacific expression vectors market revenue, by application, 2015 - 2021, (USD Million)

8.4.3. Asia Pacific expression vectors market revenue, by end-user, 2015 - 2021, (USD Million)

8.4.4. China


8.4.4.1. China expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.4.4.2. China expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.4.4.3. China expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.4.5. Japan


8.4.5.1. Japan expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.4.5.2. Japan expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.4.5.3. Japan expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.4.6. India


8.4.6.1. India expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.4.6.2. India expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.4.6.3. India expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.5. Latin America


8.5.1. Latin America expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.5.2. Latin America expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.5.3. Latin America expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.5.4. Brazil


8.5.4.1. Brazil expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.5.4.2. Brazil expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.5.4.3. Brazil expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

8.6. Middle East and Africa


8.6.1. Middle East and Africa expression vectors market revenue, by host, 2015 - 2021 (USD Million)

8.6.2. Middle East and Africa expression vectors market revenue, by application, 2015 - 2021 (USD Million)

8.6.3. Middle East and Africa expression vectors market revenue, by end-user, 2015 - 2021 (USD Million)

Chapter 9. Company Profile


9.1. Promega Corporation


9.1.1. Overview

9.1.2. Financials

9.1.3. Product portfolio

9.1.4. Business strategy

9.1.5. Recent developments

9.2. Agilent Technologies


9.2.1. Overview

9.2.2. Financials

9.2.3. Product portfolio

9.2.4. Business strategy

9.2.5. Recent developments

9.3. New England Biolabs


9.3.1. Overview

9.3.2. Financials

9.3.3. Product portfolio

9.3.4. Business strategy

9.3.5. Recent developments

9.4. Sigma-Aldrich Corporation


9.4.1. Overview

9.4.2. Financials

9.4.3. Product portfolio

9.4.4. Business strategy

9.4.5. Recent developments

9.5. Thermo Fisher Scientific


9.5.1. Overview

9.5.2. Financials

9.5.3. Product portfolio

9.5.4. Business strategy

9.5.5. Recent developments

9.6. Bio-Rad Laboratories


9.6.1. Overview

9.6.2. Financials

9.6.3. Product portfolio

9.6.4. Business strategy

9.6.5. Recent developments

9.7. Merck Millipore


9.7.1. Overview

9.7.2. Financials

9.7.3. Product portfolio

9.7.4. Business strategy

9.7.5. Recent developments

9.8. QIAGEN


9.8.1. Overview

9.8.2. Financials

9.8.3. Product portfolio

9.8.4. Business strategy

9.8.5. Recent developments

9.9. Clontech Laboratories, Inc


9.9.1. Overview

9.9.2. Financials

9.9.3. Product portfolio

9.9.4. Business strategy

9.10. GenScript USA Inc


9.10.1. Overview

9.10.2. Financials

9.10.3. Product portfolio

9.10.4. Business strategy

9.10.5. Recent developments